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Urinary tract obstruction during renal development leads to
tubular atrophy and interstitial fibrosis. Inflammatory
macrophages are crucial in this process, and b2-integrins play
a major role in leukocyte recruitment. We investigated the
role of b2-integrins and their major counter-receptors
(intercellular adhesion molecule-1 (ICAM-1), receptor for
advanced glycation endproducts (RAGE), junctional adhesion
molecule (JAM)-C) in obstructive nephropathy in neonatal
mice. Two-day-old b2-integrin-deficient mice (Mac-1
/ and
LFA-1/(deficient for leukocyte function-associated
antigen-1)) and wild-type mice (C57BL/6) underwent
unilateral ureteral obstruction (UUO) or sham operation.
After 1, 5 or 12 days of obstruction, renal macrophage
infiltration and tubulointerstitial damage were quantitated.
Tissue abundance of Mac-1 and its ligands ICAM-1, RAGE
and JAM-C was examined by Western blot and
immunoprecipitation. Deficiency of either integrin was
associated with reduced early macrophage invasion into the
obstructed kidney. After 12 days of UUO, macrophage
infiltration and tubulointerstitial injury were reduced only in
Mac-1/ but not in LFA-1/ mice. Besides ICAM-1, an
upregulation of two novel Mac-1 ligands, RAGE and JAM-C
were observed, however, with distinct time courses. We
conclude that b2-integrins mediate macrophage infiltration in
UUO. Mac-1 is the predominant leukocyte integrin involved
in leukocyte recruitment after obstruction. ICAM-1 and its
new ligands RAGE and JAM-C are sequentially activated in
UUO. Blocking of Mac-1 and its ligands may confer
synergistic renoprotective effects in neonatal obstructive
nephropathy.
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Congenital obstructive nephropathy is a major cause of
kidney failure in infants and children.1 Chronic unilateral
ureteral obstruction (UUO) leads to interstitial inflamma-
tion, interstitial fibrosis and tubular atrophy.2,3 Central to
these events is the acute macrophage infiltration of the
tubulointerstitium, which is preceded by local upregulation
of macrophage chemokines and adhesion molecules.4–11
Macrophages contribute to the tubulointerstitial injury by
releasing proinflammatory cytokines and cytotoxic sub-
stances,12,13 by inducing apoptosis in tubular cells14 and by
activating interstitial fibroblasts.15,16 Although the selective
infiltration of the interstitium by macrophages in UUO is
well established,17,18 the molecular mechanisms underlying
the recruitment of these immune cells in UUO are poorly
defined. In particular, although the expression of b2-integrins
and their major endothelial ligand intercellular adhesion
molecule-1 (ICAM-1) has been investigated in UUO,19,20
there are no comprehensive studies assessing the functional
role of these molecules in the pathogenesis of UUO.
The recruitment of leukocytes from the circulation and
their subsequent influx into surrounding tissues at sites of
inflammation or injury requires multistep adhesive and
signalling events, including selectin-mediated capture and
rolling, leukocyte activation, integrin-mediated firm adhe-
sion and their subsequent transendothelial migration.21
During firm adhesion of leukocytes to the endothelium,
members of the b2-integrin family, leukocyte function-
associated antigen-1 (LFA-1) (aLb2, CD11a/CD18) and
Mac-1 (aMb2, CD11b/CD18) on the leukocyte surface,
interact with endothelial counter-receptors such as ICAM-1
and surface-associated fibrinogen. LFA-1 and Mac-1 are
exclusively expressed on leukocytes. Whereas LFA-1 con-
tributes to leukocyte rolling by stabilizing the transient
attachment, Mac-1 contributes to emigration from the vessel,
suggesting that LFA-1 and Mac-1 serve sequential rather than
parallel functions.22,23 In UUO, expression of ICAM-1 has
been shown by immunohistochemistry on tubular epithelial
cells, interstitial cells and endothelial cells.24 However, in
ICAM-1 antisense oligonucleotide-treated mice, macrophage
infiltration following UUO was reduced but not eliminated,
suggesting that additional b2-integrin counter-receptors may
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be operative in leukocyte recruitment.25 Recently, receptor
for advanced glycation endproducts (RAGE), a multiligand
receptor on vascular cells centrally involved in inflammatory
processes,26 was identified as a new b2-integrin counter-
ligand. RAGE binds to Mac-1 but not to LFA-1.27 RAGE is
expressed at low levels in normal tissues but becomes
upregulated at inflammatory sites where its ligands accumu-
late.28–30 Other ligands for the b2-integrins include the family
of junctional adhesion molecules (JAMs). JAMs are a family
of three glycoproteins (JAM-A, -B, -C) participating in
junction assembly, platelet activation and leukocyte transmi-
gration.31–33 JAMs localize to intercellular junctions of
polarized endothelial and epithelial cells, but are also
expressed on leukocytes and platelets. JAM-C is expressed
in vascular endothelial cells, including high endothelial
venules, in epithelial cells and platelets.34 JAM-C binds to
Mac-1 but not to LFA-1 and has a direct role in leukocyte
transmigration.35,36
Because most glomeruli continue to form postnatally in
mice, renal development in the neonatal mouse is analogous
to renal development in the human fetus. For this reason,
surgical ligation of one ureter in newborn mice is a model to
study the effects of urinary tract obstruction on renal
development. The present study was designed to characterize
the role of the b2-integrins and their ligands (ICAM-1,
RAGE, JAM-C) in UUO in newborn mice.
RESULTS
Normal kidney morphology in LFA-1/ and Mac-1/ mice
LFA-1/ and Mac-1/ mice appeared healthy and devel-
oped without apparent defects. The kidneys from the LFA-
1/ and Mac-1/ mutants grossly presented similar to
those from wild-type (WT) mice. Light microscopic
examinations of the kidney showed normal structure of the
kidney, that is, glomeruli, tubulointerstitium and blood
vessels (not shown). Obstructed kidneys of LFA-1/, Mac-
1/ and WT mice presented with hydronephrosis at 1, 5 and
12 days after obstruction. The degree of tubulointerstitial
injury was dependent on the b2-integrin deficiency and the
duration of obstruction. Whereas macrophage infiltration
and tubular apoptosis were noted from day 1 after UUO,
tubular atrophy and interstitial fibrosis were present from day
5 onwards.
Monocyte/macrophage recruitment
UUO resulted in a significant and progressive increase in
interstitial macrophage infiltration in all obstructed WT,
LFA-1/ and Mac-1/ kidneys when compared to sham-
operated controls and unobstructed intact opposite kidneys
(Figure 1a–c, 2a and b). b2-Integrin-deficient mice showed a
significant decrease in interstitial macrophage infiltration
into the obstructed kidney when compared to WT; both
Mac-1/ and LFA-1/ demonstrated a decrease by 97% at
day 1 after UUO (WT 112.7720, LFA-1/ 3.070.9, Mac-
1/ 2.770.7; Po0.001). At 5 days after obstruction,
Mac-1/ demonstrated a decrease by 88% (Po0.001)
and LFA-1/ showed a decrease by 74% (Po0.001) when
compared to WT (Figure 2a). Mac-1/ still showed a
significant reduction in macrophage infiltration at 12 days
after UUO (decrease by 78%, Po0.05) (Figure 1c).
A
WT
a b c
d e f
g h i
j k l
LFA-1−/− Mac-1−/−
Figure 1 | Representative photomicrographs of obstructed kid-
neys (UUO). Renal sections were stained for macrophage infiltration
(F4/80 antibody) at 12 days after UUO in control mice (a), b2-integrin-
deficient LFA-1/ mice (b) and Mac-1/ mice (c); original
magnification  400. Mac-1/ kidneys showed significantly fewer
macrophages (black). Tubular apoptosis (TUNEL) at 12 days after
obstruction in control mice (d), LFA-1/ mice (e) and Mac-1/ mice
(f); original magnification  400. Mac-1/ kidneys showed fewer
TUNEL-positive tubular cells. Periodic acid Schiff staining identified
the thickened, irregular tubular basement membrane characteristic of
tubular atrophy in: control mice (g), LFA-1/ mice (h) and Mac-1/
mice (i) at day 12 after UUO. Renal sections were stained with
Masson’s trichrome to detect interstitial collagen (blue) in: WT mice
(j), LFA-1/ mice (k) and Mac-1/ mice (l) at day 12 following UUO;
original magnification  250.
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Figure 2 | Relative area of macrophage infiltration, identified
by F4/80 antibody (a) 5 days and (b) 12 days after operation in
Mac-1/, LFA-1/ and WT mice. Twelve fields were analyzed
at a magnification of  400. Intact¼ intact opposite kidney,
UUO¼ obstructed kidney, Sham¼ sham-operated control. *Po0.05.
#Po0.05 versus sham-operated control.
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Notably, macrophage infiltration in LFA-1/ mice was not
different from that of WT at 12 days after obstruction (Figure
2b). An increase in interstitial macrophage infiltration was
also noted in the contralateral (intact opposite) kidneys in
either Mac-1/ or LFA-1/ or WT mice with UUO.
Tubular apoptosis
Tubular apoptosis was significantly increased in all ob-
structed kidneys when compared to intact opposite kidneys
at days 1, 5 and 12 after UUO (Figures 3a and b).
Interestingly, only Mac-1/ mice showed a significant
decrease in tubular apoptosis when compared to WT at all
time points measured. Tubular apoptosis in the obstructed
kidney decreased by 62% in Mac-1/ at day 1, by 51% at day
5 and by 35% at day 12 after UUO, when compared to both
WT and LFA-1/ (Po0.05) (Figures 1d–f). LFA-1/ mice
showed a decrease in tubular apoptosis by 22% at day 5,
which was not significant. At day 12 after UUO, tubular
apoptosis in the obstructed kidney of LFA-1/ mice was not
different from that of WT but significantly higher than that
in Mac-1/ (Po0.05) (Figure 3b).
Tubular atrophy
Tubular atrophy in the obstructed kidney was detectable as
early as 5 days after UUO (Figure 4a). At 12 days after UUO,
there was a dramatic increase in thickened and sometimes
duplicated tubular basement membranes in WT mice
(Figure 1g–i and 4b). By contrast, tubular atrophy in Mac-
1/ mice was lower by 48% at day 5, and by 41% at day 12
after UUO, compared to both WT and LFA-1/ (Po0.05).
The number of atrophic tubules was not different in LFA-1/
mice compared to that in WT. Intact opposite kidneys and
sham-operated controls had no signs of tubular atrophy.
Interstitial fibrosis
Collagen deposition was clearly stained and confined to the
renal interstitium. In obstructed kidneys of WT, Mac-1/
and LFA-1/ mice at 5 and 12 days after UUO, interstitial
collagen was markedly increased in the interstitial space
compared with intact opposite kidneys and sham-operated
controls (Figure 5a and b). The deposition of interstitial
collagen in UUO was significantly less pronounced in Mac-
1/ mice than in WT or LFA-1/ mice at 12 days after
UUO (Figure 1j–l). Mac-1/ showed a decrease in
interstitial fibrosis by 25% at day 5 after UUO, and by 32%
at day 12 after UUO, when compared to WT (Po0.05). At
day 1 after obstruction, as well as in intact opposite controls
and sham-operated kidneys, there was no interstitial collagen
deposition in b2-integrin-deficient and WT mice at all time
points studied.
Expression of Mac-1 ligands in UUO
ICAM-1 protein was present in obstructed and non-
obstructed kidneys, being highest 24 h after obstruction,
followed by a gradual downregulation to day 12 after
obstruction in UUO kidneys (Figure 6). ICAM-1 abundance
normalized to b-actin was significantly higher in obstructed
kidneys than in sham-operated controls. RAGE protein
(42–46 kDa) is constitutively expressed in the skin and the
lung, but inducible in other organs such as the kidney. Lung
tissue was used as a positive control. RAGE was present in
obstructed and non-obstructed kidneys, being highest 24 h
after obstruction, followed by a gradual downregulation to
day 12 after obstruction in UUO kidneys (Figure 6). RAGE
abundance was significantly increased in UUO tissue lysates
immunoprecipitated with Mac-1, but not in LFA-1 immu-
noprecipitates, indicative of the colocalization of Mac-1 and
RAGE on infiltrating macrophages in the kidney (Figure 7).
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Figure 3 | Density of apoptotic tubular cells, identified by TUNEL
technique (a) 5 days and (b) 12 days after operation in Mac-1/,
LFA-1/ and WT mice. Twelve fields were analyzed at a
magnification of  400. Intact¼ intact opposite kidney,
UUO¼ obstructed kidney, Sham¼ sham-operated control. *Po0.05.
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Figure 4 | Density of atrophic tubules, identified by periodic acid
Schiff staining (a) 5 days and (b) 12 days after operation in
Mac-1/, LFA-1/ and WT mice. Twelve fields were analyzed
at a magnification of  400. Intact¼ intact opposite kidney,
UUO¼ obstructed kidney, Sham¼ sham-operated control. *Po0.05.
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Figure 5 | Relative area of interstitial collagen, identified by
Masson trichrome staining, (a) 5 days and (b) 12 days after
operation in Mac-1/, LFA-1/ and WT mice. Twelve fields were
analyzed at a magnification of  400. Intact¼ intact opposite kidney,
UUO¼ obstructed kidney, Sham¼ sham-operated control. *Po0.05.
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The expression of JAM-C (42 kDa) exhibited a different time
course with a steady increase during the first 2 weeks
following UUO (Figure 6). Moreover, we studied the
localization of JAM-C and ICAM-1 in obstructed and
sham-operated WT kidneys. JAM-C was clearly stained and
localized to the juxtaglomerular arterioles (Figure 8a and b).
Following UUO, JAM-C expression was markedly increased
at day 12. Some distal tubular structures (macula densa area)
showed positive staining after UUO as well (Figure 8a). In
contrast, sham-operated control kidneys demonstrated only
weak expression of JAM-C on the endothelial cells of the vasa
afferens and efferens of the glomeruli (Figure 8c). ICAM-1
expression was clearly stained and localized to the tubular
cells, renal interstitium and vessels of obstructed kidneys
(Figure 8d–f).
DISCUSSION
This study addresses the role of the b2-integrins LFA-1 and
Mac-1 and their ligands ICAM-1, RAGE and JAM-C in
tubulointerstitial renal disease induced by UUO. We showed
that b2-integrins mediate macrophage infiltration in ob-
structive nephropathy in newborn mice. The absence of
either Mac-1 (Mac-1/ mice) or LFA-1 (LFA-1/ mice)
was associated with a marked reduction in macrophage
infiltration into the tubulointerstitium compared to WT
controls during the first week following UUO. The decrease
in macrophage influx was more pronounced in Mac-1/
mice than in LFA-1/ mice at day 12 after obstruction,
demonstrating the predominant role of Mac-1 in leukocyte
recruitment following UUO. This decrease in macrophage
infiltration cannot be explained by reduced leukocyte or
mononuclear cell counts in Mac-1- and LFA-1-deficient
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Figure 6 | Expression of Mac-1 ligands (ICAM-1, RAGE and JAM-C)
in obstructed WT kidneys at 1, 5 and 12 days after obstruction
and in sham-operated controls at 5 days after surgery by
Western blot analysis. In UUO kidneys, ICAM-1 and RAGE
(42–45 kDa) expression peaked early at 24 h after obstruction and
were downregulated over time. JAM-C (42 kDa) expression increased
by day 5 and peaked late at day 12 after UUO, serving as ligand for
Mac-1 but not for LFA-1. b-Actin (42 kDa) demonstrated equal
loading (shown for JAM-C). *Po0.05.
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Figure 7 | Western blot for RAGE on Mac-1 immunoprecipitated
membrane. After immunoprecipitation for Mac-1, RAGE was
significantly upregulated in UUO kidneys at day 5 after obstruction,
suggesting colocalization of Mac-1 and RAGE on macrophages.
Kidney samples from day 5 after UUO without immunoprecipitation
for Mac-1 served as control. Lung tissue was used as a positive
control for RAGE. UUO¼ obstructed kidney, IO¼ intact opposite
(contralateral) kidney, sham¼ sham-operated control kidney.
*Po0.05.
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Figure 8 | Representative photomicrograph of JAM-C and ICAM-1
expression in obstructed and control kidneys. JAM-C localizes to
the afferent and efferent arterioles of the juxtaglomerulus apparatus
and is upregulated 12 days following UUO (a and b). Some tubular
structures of the macula densa seem to be JAM-C positive as well (a).
Sham-operated control kidneys show reduced JAM-C expression (c).
Original magnification of  400. ICAM-1 localizes to the tubular cells
and tubulointerstitial space at (d) 1 day and (e) 12 days after UUO.
Control section without primary ICAM-1 antibody (f). Original
magnification  250.
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mice, because b2-integrin-deficient mice display varying
degrees of leukocytosis.22 In addition, Mac-1/ but not
LFA-1/ mice, were partially protected from tubulointer-
stitial damage after obstruction: tubular apoptosis, tubular
atrophy and interstitial fibrosis were markedly reduced in
Mac-1/ but not in LFA-1/ mice. These results strongly
indicate that Mac-1 plays a dominant role in the initiation
and progression of obstructive nephropathy, and that other
adhesion molecules are not able to compensate for the loss of
this b2-integrin.
The mechanisms underlying the distinct phenotypes of
Mac-1- and LFA-1-deficient mice in the UUO model might
be several: first, the distinct expression of the b2-integrin
counter-receptors may determine the functional role of each
of these two b2-integrins. In particular, both Mac-1 and LFA-
1 seem to be important for early macrophage recruitment.
This period overlaps with the expression of ICAM-1, which is
a ligand for both integrins. In contrast, late macrophage
recruitment is only diminished in Mac-1-deficient mice. At
this point, ICAM-1 is downregulated and JAM-C is
upregulated, and consistent with previous reports, JAM-C
acts as a ligand only for Mac-1.34,36 This also explains why
late macrophage recruitment recovers in LFA-1-deficient
mice to a degree comparable to WT mice. Secondly, Mac-1
and LFA-1 have been reported to display different functions
in several aspects. For example, only Mac-1, but not LFA-1,
can interact with components of the fibrinolytic system, such
as plasminogen and urokinase, and modulate the pericellular
proteolytic activity of leukocytes in concert with the
urokinase receptor.37,38 Moreover, Mac-1 directly interacts
with the urokinase receptor, whereas LFA-1 does not.39
Accordingly, the phenotype of Mac-1-deficient mice in UUO
shares some similarities with the phenotype of the urokinase
receptor-deficient mice in the same model.11
The b2-integrins and their ligands mediate macrophage
infiltration in other models of kidney diseases. In diabetic
nephropathy, the expression of the b2-integrin ligand ICAM-
1 was associated with the progression of kidney disease.40
Mac-1 participates in leukocyte activation, recruitment and
the development of immune complex glomerulonephritis in
several models.41,42 In UUO, expression of Mac-1 and its
ligand ICAM-1 in the obstructed kidney has been demon-
strated by immunohistochemistry.19,25 Recently, Yamagishi
et al.24 could show that genetically modified cells expressing
Mac-1 are capable of migration to sites of ICAM-1 expression
and deliver anti-inflammatory cytokines in UUO. ICAM-1
expression has been shown in the interstitium in areas of
intense macrophage infiltration, in tubular epithelial cells and
vessels of the renal cortex after UUO.20,24 Whereas ICAM-1
was expressed within 3 days after UUO induction in adult
mice, peaking at day 5 and remaining high up to day 14,24 we
observed a different pattern of expression in neonatal UUO.
ICAM-1 protein abundance was highest at 24 h after
obstruction, followed by a gradual downregulation to day
14. In addition, we could show that the newly discovered
Mac-1 counter-receptors RAGE and JAM-C are weakly
expressed (RAGE) or not yet upregulated (JAM-C) at 24 h
after obstruction. This demonstrates the predominant role of
ICAM-1 as counter-receptor for Mac-1 and LFA-1 in early
stages of neonatal UUO. Besides leukocyte recruitment and
proliferation of macrophages in situ, different residence times
within the obstructed kidney may also contribute to the net
accumulation of leukocytes after UUO.
While RAGE is constitutively expressed during embryonic
development, its expression is downregulated in most organs
in adult life.43 Macrophages, endothelial cells, neuronal cells
and fibroblasts do not express significant amounts of RAGE
under physiological conditions, but can be induced to express
RAGE at inflammatory sites where its ligands accumu-
late.28–30 Recently, it has been shown that RAGE functions as
an endothelial adhesion receptor during inflammation that
directly interacts with Mac-1, thereby mediating leukocyte
recruitment.27,44 Consistently, RAGE abundance was signifi-
cantly increased in UUO tissue lysates immunoprecipitated
with Mac-1, but not in LFA-1 immunoprecipitates, also
suggesting the colocalization of Mac-1 and RAGE on
infiltrating macrophages in the kidney.
JAM-C, another ligand for Mac-1, was highly upregulated
following obstruction. JAM-C expression increased 5 days
after UUO and increased further on day 12 in obstructed
kidneys, showing a delayed pattern compared to ICAM-1 and
RAGE. Being strategically located at the apical part of
intercellular spaces, this JAM protein plays an important role
in inflammation and, in particular, during the passage of
leukocytes across interendothelial spaces.45,46 Thus, in the
UUO model, the binding of Mac-1 to JAM-C may facilitate
leukocyte infiltration into the obstructed kidneys, guiding the
various leukocyte subsets to the appropriate sites of
activation and effector function. Although the expression of
JAM-C on endothelial cells is consistent with its role in
leukocyte recruitment, juxtaglomerular arterioles have not
been shown to participate in leukocyte transmigration. We
also observed some staining on non-vascular structures in the
distal tubule. This suggests that JAM-C may be involved in
additional functions to those associated with leukocyte
extravasation, such as the tubular barrier function.
In conclusion, this study demonstrates that the b2-integrin
Mac-1 is an important mediator of macrophage infiltration
in UUO, leading to tubular apoptosis, tubular atrophy and
interstitial fibrosis. The expression of its ligands follows a
distinct pattern and may thereby contribute to the tubulo-
interstitial injury. The Mac-1 interaction with JAM-C seems
to be of pivotal importance. Inhibition of the b2-integrin
Mac-1 and its ligands could be an attractive approach to
protect kidneys from progressive obstructive nephropathy.
MATERIALS AND METHODS
Experimental protocol
LFA-1/ mice, deficient for leukocyte function-associated antigen-
1 (LFA-1, aLb2, CD11a/CD18), as recently described,47 and Mac-1/
mice, deficient for the Mac-1 integrin (aMb2, CD18/CD11b)48
were kindly provided by Dr C Ballantyne, Baylor College Houston,
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Texas. Mutant mice were backcrossed into a C57BL/6 background
for at least six generations and maintained in specific pathogen-free
conditions. Integrin deficiency was confirmed by polymerase chain
reaction. WT mice of the same genetic background (C57BL/6) were
used as controls. Forty-eight hours after birth, male and female mice
were subjected to complete left ureteral obstruction (n¼ 18 in each
group of WT, LFA-1/ and Mac-1/ mice) or a sham operation
(n¼ 18 in each group of WT, LFA-1/ and Mac-1/ mice) under
general anesthesia with isoflurane and oxygen. With the aid of a
Wild M3Z stereomicroscope (Leica, Heerbrugg, Switzerland), the
distal ureter was exposed through a longitudinal 5-mm left
abdominal incision and ligated twice with 6-0 silk suture. In
sham-operated animals, the ureter was exposed and repositioned
without further manipulation. Neonatal mice were killed at 1, 5 and
12 days after obstruction (n¼ 6 in each group). The experimental
protocol was approved by the Ethics Review Commitee for Animal
Experimentation of the University of Virginia and the Commitee for
Animal Experimentation of the University of Heidelberg.
Identification and quantitation of infiltrating monocytes/
macrophages
Infiltration of monocytes/macrophages was examined by immuno-
histochemistry as previously described.9 Formalin-fixed, paraffin-
embedded 3 mm sections were subjected to antigen retrieval and
incubated with rat anti-mouse monoclonal F4/80 antibody (super-
natant from F4/80 hybridoma cells; ATCC, Manassas, VA) against
monocytes/macrophages. Digital images of the sections (n¼ 6 in
each group) were superimposed on a grid, and the number of grid
points overlapping dark brown macrophages in the cortex and
medulla was recorded for each field. Twelve non-overlapping fields
at  400 magnification were analyzed in a blinded fashion. Twelve
fields at  400 magnification covered the whole obstructed kidney,
especially in very young kidneys at day 1 after obstruction. Data
were expressed as the mean score7s.e.m. per 12 high-power fields.
Representative photomicrographs of macrophage infiltration are
shown in Figure 1a–c.
Localization of JAM-C and ICAM-1
The abundance of JAM-C and ICAM-1 in WT mice kidneys was
examined by immunohistochemistry. Sections were subjected to
antigen retrieval. Sections were preincubated in a blocking solution
(10% goat serum in phosphate-buffered saline or power block,
respectively) for 20 min and incubated either overnight at 41C with
monoclonal anti-JAM-C antibody (HM 1057; HyCult Biotechnol-
ogy, Uden, The Netherlands) or with the anti-mouse ICAM-1
antibody (Santa Cruz Biotechnology Inc., CA) for 1 h at 371C.
Biotinylated goat anti-rat IgG and rabbit anti-goat IgG (Southern
Biotechnology Associates, Inc., Birmingham, AL) were used as
second antibodies. Sections were incubated for 30 min with ABC
reagent (Vectastain, Vector Laboratories, Burlingame, CA). Each
section was placed in diaminobenzidine/hydrogen peroxide solu-
tion, and counterstained with methylene blue or hemalaun.
Representative photomicrographs of JAM-C and ICAM-1 expres-
sion are shown in Figure 8a–f.
Detection of apoptosis
As described previously,49 apoptotic cells were detected by the
terminal deoxynucleotidyl transferase-mediated deoxyuridine tri-
phosphate-biotin nick-end labeling (TUNEL) assay (ApopTag
Peroxidase In Situ Apoptosis Detection Kit, Intergen, Purchase,
NY). Cells were regarded as TUNEL positive if their nuclei were
stained brown and displayed typical apoptotic morphology with
chromatin condensation. The number of TUNEL-positive cells in
each kidney was calculated in a blinded fashion by counting the
number of TUNEL-positive tubular cells in 12 sequentially selected
fields at  400 magnification and expressed as the mean
number7s.e. per 12 high-power fields (n¼ 6 in each group).
Representative photomicrographs of tubular apoptosis are shown in
Figure 1d–f.
Measurement of tubular atrophy
Kidney sections were stained with periodic acid Schiff for assessment
of tubular basement membranes, and tubular atrophy was
determined as described previously.50 Atrophic tubules were
identified by their thickened and sometimes duplicated basement
membranes. The number of atrophic tubules per field at  400
magnification was counted, and 12 fields/kidney were analyzed.
Representative photomicrographs of tubular atrophy are shown in
Figure 1g–i.
Morphometric evaluation of the interstitial fibrosis of the
renal cortex
Interstitial collagen deposition was measured in Masson trichrome-
stained sections as described before.51 Digital images of the sections
were superimposed on a grid and the number of grid points
overlapping interstitial blue-staining collagen was recorded for each
field. Twelve non-overlapping fields at  400 magnification were
analyzed. Representative photomicrographs of interstitial fibrosis are
shown in Figure 1j–l.
Antibodies
Anti-LFA-1 antibody (M17-4), anti-Mac-1 antibody (M-19) and
anti-ICAM-1 antibody (M-19) were purchased from Santa Cruz
Biotechnology Inc. CA. Goat anti-RAGE antibody was obtained
from Merck, Sharpe and Dhome (Harlow, UK). Anti-JAM-C
antibody (HM 1057) was purchased from HyCult Biotechnology
(Uden, The Netherlands). The anti-mouse JAM-C antibody used for
Western blot studies was kindly provided by Dr B Imhof (University
of Geneva, Switzerland).
Western immunoblotting
Additional 24 neonatal WT mice underwent UUO surgery or sham
operation at the second day of life. Kidneys were harvested 1, 5 and
12 days after obstruction (n¼ 4 in each group), homogenized in
protein extraction buffer (Triton-X 100 1%, Tris 100 mM, Na4P2O3
100 mM, NaF 100 mM, ethylenediaminetetraacetic acid 10 mM)
containing a cocktail of proteinase and phosphatase inhibitors
(1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml
leupeptin, 10 mg/ml aprotinin), and centrifuged for 60 min at
20 000 g. Fifty micrograms of protein were separated on polyacry-
lamide gels at 180 V for 45 min and blotted onto nitrocellulose
membranes (105 V, 80 min). After blocking for 1 h in Tris-buffered
saline with Tween 20 containing 5% nonfat dry milk, blots were
incubated with primary antibodies at 41C overnight. Blots were
washed with Tris-buffered saline with Tween 20 and incubated with
horseradish peroxidase-conjugated secondary antibody for 1 h at
room temperature. Immune complexes were detected using
enhanced chemiluminescence (Amersham Pharmacia Biotech,
Freiburg, Germany). Blots were exposed to X-ray films (Kodak,
Stuttgart, Germany), and protein bands were quantified using
densitometry. Each band represents one single mouse kidney.
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Immunoprecipitation
For immunoprecipitation, additional eight neonatal WT mice
underwent UUO or sham operation within 48 h after birth. Kidneys
were harvested 5 days after obstruction (n¼ 4 in each group). The
kidney homogenization for immunoprecipitation was performed in
200ml radioimmunoprecipitation assay-buffer (50 ml phosphate-
buffered saline, 500 ml IGEPAL CA-630, 250 mg sodium deoxycho-
late, 500 ml 10% sodium dodecyl sulfate) containing a cocktail of
proteinase and phosphatase inhibitors (1 mM Na3VO4, 1 mM
phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, 10 mg/ml apro-
tinin, 3 mM benzamidine). Kidney samples were further processed by
passing through a 20-gauge needle and syringe several times and
centrifuged at 16 000 g for 10 min. The supernatant was then
incubated with 10 ml of the indicated antibodies on a shaker for 2 h
at 41C. Twenty microliters protein A/G agarose beads were added.
After overnight incubation, lysates were centrifuged at 1000 g for
10 min at 41C. The pellets were washed, resuspended in electro-
phoresis buffer, and immunoblotted as described above. Each band
represents one single kidney.
Statistical analysis
Data are presented as mean7s.e. Comparisons between groups were
made using one-way analysis of variance followed by the
Student–Newman–Keuls test. Comparisons between left and right
kidneys were performed using the Student’s t-test for paired data.
Statistical significance was defined as Po0.05.
ACKNOWLEDGMENTS
This research was supported in part by National Institutes of Health
DK52612 grant to Dr Robert L Chevalier. Dr Ba¨rbel Lange-Sperandio is
supported by a stipend from the German Research Foundation (DFG)
La 1257/2-1. This work was in part supported by a grant from the
European Foundation for the Study of Diabetes (AB) and by the SFB
405 to PN and TC. We thank Dr Christie Ballantyne, Baylor College
Houston, for providing LFA-1- and Mac-1-deficient mice, and Dr Klaus
Ley, University of Virginia, for providing murine breeding pairs.
REFERENCES
1. Fivush BA, Jabs K, Neu AM et al. Chronic renal insufficiency in children
and adolescents: the 1996 annual report of NAPRTCS. North American
Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1998; 12:
328–337.
2. Chevalier RL. Perinatal obstructive nephropathy. Semin Perinatol 2004; 28:
124–131.
3. Liapis H. Biology of congenital obstructive nephropathy. Nephron Exp
Nephrol 2003; 93: e87–e91.
4. Klahr S. Urinary tract obstruction. Semin Nephrol 2001; 21: 133–145.
5. Diamond JR, Kees-Folts D, Ding G et al. Macrophages, monocyte
chemoattractant peptide-1, and TGF-beta 1 in experimental hydrone-
phrosis. Am J Physiol 1994; 266: F926–F933.
6. Ricardo SD, Levinson ME, DeJoseph MR, Diamond JR. Expression of
adhesion molecules in rat renal cortex during experimental hydrone-
phrosis. Kidney Int 1996; 50: 2002–2010.
7. Shappell SB, Mendoza LH, Gurpinar T et al. Expression of adhesion
molecules in kidney with experimental chronic obstructive uropathy:
the pathogenic role of ICAM-1 and VCAM-1. Nephron 2000; 85:
156–166.
8. Ophascharoensuk V, Giachelli CM, Gordon K et al. Obstructive uropathy in
the mouse: role of osteopontin in interstitial fibrosis and apoptosis.
Kidney Int 1999; 56: 571–580.
9. Lange-Sperandio B, Cachat F, Thornhill BA, Chevalier RL. Selectins
mediate macrophage infiltration in obstructive nephropathy in
newborn mice. Kidney Int 2002; 61: 516–524.
10. Vielhauer V, Anders HJ, Mack M et al. Obstructive nephropathy in the
mouse: progressive fibrosis correlates with tubulointerstitial chemokine
expression and accumulation of CC chemokine receptor 2- and 5-positive
leukocytes. J Am Soc Nephrol 2001; 12: 1173–1187.
11. Zhang G, Kim H, Cai X et al. Urokinase receptor modulates cellular and
angiogenic responses in obstructive nephropathy. J Am Soc Nephrol
2003; 14: 1234–1253.
12. Ricardo SD, Diamond JR. The role of macrophages and reactive oxygen
species in experimental hydronephrosis. Semin Nephrol 1998; 18:
612–621.
13. Hirschberg R, Wang S. Proteinuria and growth factors in the development
of tubulointerstitial injury and scarring in kidney disease. Curr Opin
Nephrol Hypertens 2005; 14: 43–52.
14. Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier RL. Macrophages
induce apoptosis in proximal tubule cells. Pediatr Nephrol 2003; 18:
335–341.
15. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in
streptozotocin-induced diabetic nephropathy: potential role in renal
fibrosis. Nephrol Dial Transplant 2004; 19: 2987–2996.
16. Diamond JR. Macrophages and progressive renal disease in experimental
hydronephrosis. Am J Kidney Dis 1995; 26: 133–140.
17. Shappell SB, Gurpinar T, Lechago J et al. Chronic obstructive uropathy in
severe combined immunodeficient (SCID) mice: lymphocyte infiltration is
not required for progressive tubulointerstitial injury. J Am Soc Nephrol
1998; 9: 1008–1017.
18. Le Meur Y, Tesch GH, Hill PA et al. Macrophage accumulation at a site of
renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc
Biol 2002; 72: 530–537.
19. Takeda A, Fukuzaki A, Kaneto H et al. Role of leukocyte adhesion
molecules in monocyte/macrophage infiltration in weanling rats with
unilateral ureteral obstruction. Int J Urol 2000; 7: 415–420.
20. Kriegsman J, Muller H, Sommer M et al. Expression of LFA-1 (CD11a/
CD18) and ICAM-1 (CD54) in an animal model of renal interstitial fibrosis
induced by unilateral ureteral obstruction. Exp Toxicol Pathol 2000; 52:
185–191.
21. Butcher EC. Leukocyte–endothelial cell recognition – three (or more) steps
to specificity and diversity. Cell 1991; 67: 1033–1036.
22. Dunne JL, Collins RG, Beaudet AL et al. Mac-1, but not LFA-1, uses
intercellular adhesion molecule-1 to mediate slow leukocyte rolling in
TNF-alpha-induced inflammation. J Immunol 2003; 171: 6105–6111.
23. Henderson RB, Lim LH, Tessier PA et al. The use of lymphocyte function-
associated antigen (LFA)-1-deficient mice to determine the role of LFA-1,
Mac-1, and alpha4 integrin in the inflammatory response of neutrophils.
J Exp Med 2001; 194: 219–226.
24. Yamagishi H, Yokoo T, Imasawa T et al. Genetically modified bone
marrow-derived vehicle cells site specifically deliver an anti-inflammatory
cytokine to inflamed interstitium of obstructive nephropathy. J Immunol
2001; 166: 609–616.
25. Cheng QL, Chen XM, Li F et al. Effects of ICAM-1 antisense oligonucleo-
tide on the tubulointerstitium in mice with unilateral ureteral obstruction.
Kidney Int 2000; 57: 183–190.
26. Liliensiek B, Weigand MA, Bierhaus A et al. Receptor for advanced
glycation end products (RAGE) regulates sepsis but not the adaptive
immune response. J Clin Invest 2004; 113: 1641–1650.
27. Chavakis T, Bierhaus A, Al Fakhri N et al. The pattern recognition
receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel
pathway for inflammatory cell recruitment. J Exp Med 2003; 198:
1507–1515.
28. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as
a progression factor amplifying immune and inflammatory responses.
J Clin Invest 2001; 108: 949–955.
29. Abel M, Ritthaler U, Zhang Y et al. Expression of receptors for advanced
glycosylated end-products in renal disease. Nephrol Dial Transplant 1995;
10: 1662–1667.
30. Wendt TM, Tanji N, Guo J et al. RAGE drives the development of
glomerulosclerosis and implicates podocyte activation in the
pathogenesis of diabetic nephropathy. Am J Pathol 2003; 162:
1123–1137.
31. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin
Cell Biol 2003; 15: 525–530.
32. Ebnet K, Suzuki A, Ohno S, Vestweber D. Junctional adhesion molecules
(JAMs): more molecules with dual functions? J Cell Sci 2004; 117: 19–29.
33. Keiper T, Santoso S, Nawroth PP et al. The role of junctional adhesion
molecules in cell–cell interactions. Histol Histopathol 2005; 20: 197–203.
34. Santoso S, Sachs UJ, Kroll H et al. The junctional adhesion molecule 3
(JAM-3) on human platelets is a counterreceptor for the leukocyte
integrin Mac-1. J Exp Med 2002; 196: 679–691.
35. Johnson-Leger CA, Aurrand-Lions M, Beltraminelli N et al. Junctional
adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial
migration. Blood 2002; 100: 2479–2486.
Kidney International (2006) 69, 81–88 87
B Lange-Sperandio et al.: b2-Integrins in obstructive nephropathy o r i g i n a l a r t i c l e
36. Zen K, Babbin BA, Liu Y et al. JAM-C is a component of desmosomes and
a ligand for CD11b/CD18-mediated neutrophil transepithelial migration.
Mol Biol Cell 2004; 15: 3926–3937.
37. Pluskota E, Soloviev DA, Plow EF. Convergence of the adhesive and
fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2
as well as by the urokinase receptor regulates cell adhesion and
migration. Blood 2003; 101: 1582–1590.
38. Pluskota E, Soloviev DA, Bdeir K et al. Integrin alphaMbeta2 orchestrates
and accelerates plasminogen activation and fibrinolysis by neutrophils.
J Biol Chem 2004; 279: 18063–18072.
39. Simon DI, Wei Y, Zhang L et al. Identification of a urokinase receptor-
integrin interaction site. Promiscuous regulator of integrin function. J Biol
Chem 2000; 275: 10228–10234.
40. Matsui H, Suzuki M, Tsukuda R et al. Expression of ICAM-1 on glomeruli is
associated with progression of diabetic nephropathy in a genetically
obese diabetic rat, Wistar fatty. Diabetes Res Clin Pract 1996; 32: 1–9.
41. Tang T, Rosenkranz A, Assmann KJ et al. A role for Mac-1 (CDIIb/CD18) in
immune complex-stimulated neutrophil function in vivo: Mac-1 defi-
ciency abrogates sustained Fcgamma receptor-dependent neutrophil
adhesion and complement-dependent proteinuria in acute glomerulo-
nephritis. J Exp Med 1997; 186: 1853–1863.
42. Soma J, Saito T, Ootaka T et al. Intercellular adhesion molecule-1,
intercellular adhesion molecule-3, and leukocyte integrins in leukocyte
accumulation in membranoproliferative glomerulonephritis type I. Am J
Kidney Dis 1996; 28: 685–694.
43. Brett J, Schmidt AM, Yan SD et al. Survey of the distribution of a newly
characterized receptor for advanced glycation end products in tissues.
Am J Pathol 1993; 143: 1699–1712.
44. Chavakis T, Bierhaus A, Nawroth PP. RAGE (receptor for advanced
glycation end products): a central player in the inflammatory response.
Microbes Infect 2004; 6: 1219–1225.
45. Vestweber D. Regulation of endothelial cell contacts during leukocyte
extravasation. Curr Opin Cell Biol 2002; 14: 587–593.
46. Chavakis T, Keiper T, Matz-Westphal R et al. The junctional adhesion
molecule-C promotes neutrophil transendothelial migration in vitro and
in vivo. J Biol Chem 2004; 279: 55602–55608.
47. Ding ZM, Babensee JE, Simon SI et al. Relative contribution of LFA-1 and
Mac-1 to neutrophil adhesion and migration. J Immunol 1999; 163:
5029–5038.
48. Lu H, Smith CW, Perrard J et al. LFA-1 is sufficient in mediating neutrophil
emigration in Mac-1-deficient mice. J Clin Invest 1997; 99: 1340–1350.
49. Cachat F, Lange-Sperandio B, Chang AY et al. Ureteral obstruction in
neonatal mice elicits segment-specific tubular cell responses leading to
nephron loss. Kidney Int 2003; 63: 564–575.
50. Chevalier RL, Thornhill BA, Chang AY et al. Recovery from release of
ureteral obstruction in the rat: relationship to nephrogenesis. Kidney Int
2002; 61: 2033–2043.
51. Fern RJ, Yesko CM, Thornhill BA et al. Reduced angiotensinogen
expression attenuates renal interstitial fibrosis in obstructive nephro-
pathy in mice. J Clin Invest 1999; 103: 39–46.
88 Kidney International (2006) 69, 81–88
o r i g i n a l a r t i c l e B Lange-Sperandio et al.: b2-Integrins in obstructive nephropathy
